Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound cetylpyridinium iodide lozenges in mild recurrent aphthous ulcer (Phase IIb)
CTR20242585Phase 2Completed
- Sponsor
- Renfu Junwei
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cetylpyridinium iodide in aphthosis (RAS), sponsored by Renfu Junwei. Started Jul 2024; status: completed.
02
Drugs
cetylpyridinium iodide
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20242585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242585.